M7824 Monotherapy in Locally Advanced or Metastatic Second Line (2L) Biliary Tract Cancer (Cholangiocarcinoma and Gallbladder Cancer)

NCT03833661 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

159

Enrollment

INDUSTRY

Sponsor class

Conditions

Biliary Tract Cancer
Cholangiocarcinoma
Gallbladder Cancer

Interventions

DRUG: M7824

Sponsor

EMD Serono Research & Development Institute, Inc.

Collaborators

[object Object]